Tissue RepairASX:TRP 29 Quick Ratio is 20.40 as of Dec. 2025, which is 35% below its 10-year median of 31.49. GuruFocus rates ASX:TRP with a GF Score™ of 29/100. Among 1,416 Biotechnology companies, Tissue Repair ranks better than 92.73% on this metric.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. Tissue Repair's quick ratio for the quarter that ended in Dec. 2025 was 20.40.
Tissue Repair has a quick ratio of 20.40. It generally indicates good short-term financial strength.
The historical rank and industry rank for Tissue Repair's Quick Ratio or its related term are showing as below:
ASX:TRP'
s Quick Ratio Range Over the Past 10 Years
Min: 14.97 Med: 31.49 Max: 73.55
Current: 20.4
During the past 5 years, Tissue Repair's highest Quick Ratio was 73.55. The lowest was 14.97. And the median was 31.49.
ASX:TRP's Quick Ratio is ranked better than 92.73% of 1416
companies
in the Biotechnology industry
Industry Median: 3.6
vs ASX:TRP: 20.40
Tissue Repair (ASX:TRP) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Tissue Repair Quick Ratio Related Terms
Tissue Repair Quick Ratio Historical Data
* Premium members only.
The historical data trend for Tissue Repair's Quick Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:TRP vs VRTX, REGN, ALNY: Quick Ratio Comparison
For the Biotechnology subindustry, Tissue Repair's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tissue Repair Quick Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Tissue Repair's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Tissue Repair's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
Tissue Repair's Quick Ratio for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tissue Repair (ASX:TRP) has a Quick Ratio of 20.40 as of Dec. 2025. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Tissue Repair and its competitors. This is 35% below median its historical median of 31.49. Over the past decade, Tissue Repair's Quick Ratio has ranged from 14.97 to 73.55. According to the industry distribution chart, Tissue Repair ranks #103 out of 1416 companies in the Biotechnology industry, placing it in the top 7.3%.
Is Tissue Repair's Quick Ratio too high?
Tissue Repair's current Quick Ratio of 20.40 is 35% below median its 10-year median of 31.49. Over the past 10 years, this metric has ranged from a low of 14.97 to a high of 73.55. The Biotechnology industry median Quick Ratio is 3.60. Tissue Repair's value of 20.40 is 466.7% above this industry median. Based on the distribution chart, Tissue Repair ranks #103 out of 1416 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Tissue Repair has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does Tissue Repair's Quick Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Tissue Repair ranks #103 out of 1416 companies for Quick Ratio. This places Tissue Repair in the top 7% of its industry — outperforming the majority of peers. The industry median Quick Ratio is 3.60. Tissue Repair's value of 20.40 is 466.7% above this benchmark. Historically, Tissue Repair's own Quick Ratio has ranged from 14.97 to 73.55 over the past decade. While the company's 10-year median is 31.49 vs. the industry median of 3.60, Tissue Repair has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Biotechnology company?
The median Quick Ratio among Biotechnology companies is 3.60, based on 1,416 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Tissue Repair's current Quick Ratio of 20.40 is 466.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Tissue Repair and its competitors. For the Biotechnology industry, the median Quick Ratio is 3.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tissue Repair's current Quick Ratio is 20.40, which is 35% below median its own 10-year median of 31.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tissue Repair stock overvalued right now?
Tissue Repair (ASX:TRP) has a current Quick Ratio of 20.40. The current Quick Ratio is 20.40, which is 35% below median its 10-year median of 31.49 and 466.7% above the Biotechnology industry median of 3.60. Tissue Repair's overall GF Score™ is 29/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Tissue Repair (ASX:TRP), the current Quick Ratio is 20.40 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Tissue Repair Ltd is a clinical-stage biopharmaceutical company engaged in development of wound healing products for chronic wounds and the aftercare of cosmetic procedures, with the potential for further development of related technologies.
29GF Score
Get the complete analysis for ASX:TRP
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:TRP has been successfully added to your 
